Valuation (24%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -4.07 | N/A |
PEG Ratio (TTM) | 0.19 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 2.63 | N/A |
P/FCF Ratio (TTM) | -4.85 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -57.13% | N/A |
ROE (TTM) | -55.92% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -20.10% | -229.58% | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -25.97% | -220.44% | N/A |
Cash Flow | -35.58% | -256.54% | N/A |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 8.55 | N/A |
Quick Ratio (TTM) | 8.55 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | 9.78 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |